Medicine

A new NASH treatment, efruxifermin, significantly reduced liver fat when combined with a GLP-1 drug in a small trial.

Osimertinib, an FDA-approved lung cancer drug, slashes the risk of death for certain patients by 51%, according to new trial results.

Researchers at Johns Hopkins have found that genes associated with schizophrenia risk may impact the placenta, not just the brain.

Gain-of-function experiments in the lab can help researchers get ahead of viruses naturally gaining the ability to infect people in the wild.

Even though pain is universal and we know it happens in the brain, we've never before had a way to objectively measure its intensity.

The first treatments proven to slow cognitive decline in Alzheimer’s are helping settle a decades-long debate about how the disease starts.

To improve leukemia treatment, Australian researchers have created a bispecific antibody that connects chemo drugs to cancer cells.

Techniques borrowed from astrophysics are helping to advance personalized cancer treatments beyond what genetics can tell us.

This protein may help bats survive viral infections and could be the springboard for new anti-inflammatory drugs.